Clinical Trials Logo

HIV-1/HBV Co-Infection clinical trials

View clinical trials related to HIV-1/HBV Co-Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03547908 Completed - Clinical trials for HIV-1/HBV Co-Infection

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Alliance
Start date: May 30, 2018
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of fixed-dose combination (FDC) of bictegravir/emtricitabine/ tenofovir alafenamide (B/F/TAF) versus dolutegravir (DTG) + emtricitabine/tenofovir disoproxil fumarate (F/TDF) in HIV and hepatitis B virus (HBV) treatment naive, HIV-1 and HBV co-infected adults.